That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
11:21 AMYahoo Finance
Boston Scientific bets on WATCHMAN growth despite market slowdown
10:35 AMPR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of investors of Boston Scientific corporation - BSXpress release
6:10 AMYahoo Finance
Boston Scientific (BSX) is back in the spotlight, what is driving attention?
12:15 PMYahoo Finance
Should Boston Scientific (BSX) investors worry about these FDA Class II recalls?
11:11 AMYahoo Finance
Boston Scientific (BSX) stock may be 38% undervalued following WATCHMAN trial news
10:15 AMYahoo Finance
Boston Scientific targets long-term growth as key businesses face pressure through 2027
8:30 AMYahoo Finance
Wall Street analysts look bullish on Boston Scientific (BSX): Should you buy?
5:06 AMYahoo Finance
What could go Wrong at Boston Scientific from here?
5:28 PMYahoo Finance
S&P revises Boston Scientific outlook to negative on franchise pressures
8:00 AMYahoo Finance
Here is what to know beyond why Boston Scientific corporation (BSX) is a trending stock
6:04 AMYahoo Finance
Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development
11:04 AMYahoo Finance
RevMedica Appoints Former Boston Scientific executive Mike Jones as chief executive Officer
8:55 AMYahoo Finance
BSX Q3 results Reset growth expectations as 2027 outlook stays weak
4:43 AMYahoo Finance
Should you pick Boston Scientific stock over its Competitors?
4:11 AMYahoo Finance
Boston Scientific (BSX) Secures $455 million for a next Generation Heart pump
8:21 AMYahoo Finance
Is BSX worth buying now as low valuation meets weak earnings growth?
7:41 AMYahoo Finance
Why did Boston Scientific stock jump?
6:16 AMYahoo Finance
Are Wall Street analysts bullish on Boston Scientific stock?
5:44 AMYahoo Finance
Boston Scientific and Blackstone agree on $455m VITALYST heart pump deal
5:54 PMYahoo Finance
Blackstone Life Sciences announces $455 million collaboration to Co-Fund development of Boston Scientific VITALYST™ heart pump for patients with cardiogenic shock
2:02 PMYahoo Finance
SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints